| 2061 |
|
P2X1: definitely not an ADP receptor/
|
Rosa, J.-P
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 2062 |
|
Patient selection and goals/
|
Vesole, D. H
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 2063 |
|
Pax5 determines B- versus T-cell fate and does not block early myeloid-lineage development/
|
Cotta, C. V
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 2064 |
|
PDE4 inhibitors activate a mitochondrial apoptotic pathway in chronic lymphocytic leukemia cells that is regulated by protein phosphatase 2A/
|
Moon, E.-Y
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 2065 |
|
PECAM-1/CD31 provides survival signals to suppress apoptosis/
|
Jackson, D. E
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 2066 |
|
PECAM-1 functions as a specific and potent inhibitor of mitochondrial-dependent apoptosis/
|
Gao, C
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 2067 |
|
PECAM-1 negatively regulates GPIb/V/IX signaling in murine platelets/
|
Rathore, V
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 2068 |
|
Penetrance in hereditary hemochromatosis/
|
McCune, A
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 2069 |
|
Peptides containing a dominant T-cell epitope from red cell band 3 have in vivo immunomodulatory properties in NZB mice with autoimmune hemolytic anemia/
|
Shen, C.-R
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 2070 |
|
Peptidoglycan recognition and neutrophil function/
|
Weiss, J
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 2071 |
|
Performance- and safety-enhanced lentiviral vectors containing the human interferon-beta scaffold attachment region and the chicken beta-globin insulator/
|
Ramezani, A
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 2072 |
|
Peripheral smear from a patient with beta thalassemia-HbE disease/
|
Schrier, S
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 2073 |
|
Peripheral T-cell lymphomas unspecified presenting in the skin: analysis of prognostic factors in a group of 82 patients/
|
Bekkenk, M. W
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 2074 |
|
Peroxiredoxin II is essential for sustaining life span of erythrocytes in mice/
|
Lee, T.-H
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 2075 |
|
Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment/
|
Bhatia, R
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 2076 |
|
Persistent gamma-globin expression in adult transgenic mice is mediated by HPFH-2, HPFH-3, and HPFH-6 breakpoint sequences/
|
Katsantoni, E. Z
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 2077 |
|
PERSPECTIVE - Chronic myeloid leukemia: current treatment options/
|
Goldman, J M
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 2078 |
|
PERSPECTIVE - Discrepancies between genotype and phenotype in hematology: An important frontier/
|
Beutler, E
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 2079 |
|
PERSPECTIVE - Probability in transcriptional regulation and its implications for leukocyte differentiation and inducible gene expression/
|
Hume, D A
|
W.B. Saunders Co., etc.]
|
2000
|
|
|
|
| 2080 |
|
PERSPECTIVE - Report of an international working group to standardize response criteria for myelodysplastic syndromes/
|
Cheson, B D
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|